For instance, a previous study has shown that targeting PRMT1 causes ferroptosis by upregulating acyl‐CoA synthetase long‐chain family member 1 (ACSL1) in AML cells.[39] Besides, silencing PRMT1 increases the necrotic cell death in colon cancer cells.[40] Thus, other forms of cell death induced by PRMT1 inhibition in CML LSCs should be further investigated. Here, PRMT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.